Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Finished Goods: 2013-2025

Historic Finished Goods for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $253.8 million.

  • Phibro Animal Health's Finished Goods rose 63.76% to $279.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $279.6 million, marking a year-over-year increase of 63.76%. This contributed to the annual value of $253.8 million for FY2025, which is 49.69% up from last year.
  • Latest data reveals that Phibro Animal Health reported Finished Goods of $253.8 million as of FY2025, which was up 49.69% from $169.6 million recorded in FY2024.
  • In the past 5 years, Phibro Animal Health's Finished Goods ranged from a high of $253.8 million in FY2025 and a low of $143.8 million during FY2021.
  • In the last 3 years, Phibro Animal Health's Finished Goods had a median value of $170.9 million in 2023 and averaged $198.1 million.
  • Per our database at Business Quant, Phibro Animal Health's Finished Goods dropped by 0.78% in 2024 and then soared by 49.69% in 2025.
  • Phibro Animal Health's Finished Goods (Yearly) stood at $143.8 million in 2021, then rose by 8.94% to $156.7 million in 2022, then grew by 9.08% to $170.9 million in 2023, then declined by 0.78% to $169.6 million in 2024, then spiked by 49.69% to $253.8 million in 2025.